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ABSTRACT
Objectives: Emergency department (ED) patients show
high smoking rates. The effects of ED-initiated tobacco
control (ETC) on 7-day abstinence at 12 months were
investigated.
Methods: A randomised controlled intention-to-treat trial
(trials registry no.: ISRCTN41527831) was conducted
with 1044 patients in an urban ED. ETC consisted of on-
site counselling plus up to four telephone booster
sessions. Controls received usual care. Analysis was by
logistic regression.
Results: In all, 630 (60.7%) participants were males, the
median age was 30 years (range 18–81) and the median
smoking intensity was 15 (range 1–60) cigarettes per
day. Overall, 580 study participants (55.6%) were
unmotivated, 331 (31.7%) were ambivalent and 133
(12.7%) were motivated smokers. ETC (median time 30
(range 1–99) min) was administered to 472 (91.7% out of
515) randomised study participants. At follow-up, 685
study participants (65.6% of 1044) could be contacted. In
the ETC group, 73 out of 515 (14.2%) in the ETC group
were abstinent, whereas 60 out of 529 (11.3%) controls
were abstinent (OR adjusted for age and gender=1.31
(95% CI 0.91 to 1.89, p=0.15). Stratified for motivation
to change behaviour, the adjusted ORs for ETC versus
usual care were OR=1.00 (95% CI 0.57 to 1.76) in
unmotivated smokers, respectively OR=1.37 (95% CI
0.73 to 2.58) in ambivalent smokers and OR=2.19 (95%
CI 0.98 to 4.89) in motivated smokers, p for trend=0.29.
Conclusions: ETC, in the form of on-site counselling with
up to four telephone booster sessions, showed no overall
effect on tobacco abstinence after 12 months. A non-
significant trend for a better performance of ETC in more
motivated smokers was observed.
Emergency department (ED) patients show a
prevalence of smoking that exceeds the smoking
prevalence in the general population.
1 Furthermore,
ED patients often have limited access to medical
care and in particular to health promotion
services.
2 With respect to the role of EDs in
delivering preventive services and improving public
health,
3 in October 2006, a joint statement of the
American Emergency Medicine Organizations
encouraged ED administrators to implement ED-
initiated tobacco control (ETC) services and
researchers to conduct evaluations of such efforts.
2
A systematic review from 2002
4 on the diagnosis
and management of smoking and smoking-related
illness in the ED identified 2 ED-based studies: a
randomised controlled trial (RCT) with 152 study
participants found no difference in quit rates (at 3-
month follow-up) in those receiving standardised,
scripted counselling including referral to a smoking
cessation program together with a ‘‘Stop Smoking’’
pamphlet from the American Heart Association
compared to controls who only received the
pamphlet. None of the intervention group joined
the smoking cessation program.
5 The second study,
which was based in a military ED, identified 42 out
of 86 smokers who were interested in quitting, of
whom 40 were randomised to receive either a
formal smoking cessation program or a brief
counselling from the ED doctor. None of the study
participants completed the smoking cessation
programme and only one patient in the brief
counselling group had stopped smoking at 6-
month follow-up.
6
Later investigations included a non-controlled
feasibility study of health promotion in an ED
setting. Of 411 smokers who accepted referral to a
smoking cessation programme, 158 were contacted
at follow-up. The quit rate was 12%, and another
40% reported reduced smoking.
7 Another feasibility
study with 39 study participants in a tertiary-care
ED found no difference in the 7-day abstinence at
6 months in either the intervention (telephone
counselling through a tobacco quitline) or control
(self-help manual) conditions.
8 In an RCT with 74
adolescents aged 14 to 19 years old in a university-
affiliated hospital ED, no differences in quit rates
were found between on-site motivational inter-
viewing plus stage-based take-home material com-
pared with usual care during the 60 month follow-
up.
91 0Bock et al
11 randomised 543 adult smokers in
an observation unit of a university-based ED to
either on-site motivational interviewing in combi-
nation with 2 telephone booster sessions or a
control condition receiving a printed referral sheet
with information on local smoking cessation
resources. In a per-protocol analysis the odds
ratio for a 7-day abstinence at 1, 3 and 6 months
was 1.62 (95% confidence interval (CI) 1.05 to
2.50) in the intervention group versus the
control group. Boudreaux et al
12 in their pilot
study with 90 adult smokers in an urban,
academic level 1 trauma centre found a 7-day
abstinence at a 3-month follow-up between 6%
(standard referral group) and 14% (motivational
interviewing per phone in combination with a
posted tailored ‘‘motivational tool’’ which con-
tained (among others) a ‘‘Personalised Feedback
Form’’ and a ‘‘Pro/Con Worksheet’’). Thus, due
to the relative heterogeneity of the type and
duration of ETC tested in previous studies, the
superiority of ETC over no treatment conditions
remains unclear.
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effectiveness of ETC, combining on-site counselling with
telephone booster sessions in a large sample of ED patients.
MATERIALS AND METHODS
Sample
Study participants were recruited in the ED at the Charite ´–
Universitaetsmedizin Berlin between 06 October 2005 and 21
December 2006. This inner city ED in the very centre of Berlin
treats approximately 40 000 patients annually. After ethical
committee approval, all patients 18 years of age or older treated
in the ED were screened for tobacco use. Those reporting a
minimum of one cigarette smoked per day during the last 7 days
were asked to participate in the study. Excluded were (1)
patients with no capacity to understand the study information
and/or no capacity to give informed consent because of acute or
chronic mental or physical conditions (intoxication, severe
injuries or organic conditions which required immediate medical
care, chronic mental illness, blindness, deafness, other handi-
caps), (2) those with no capacity to operate the computerised
screening tool (see below), (3) patients in police custody, (4)
homeless patients (or those not reachable for telephone follow-
up for other reasons), (5) patients unable to read and
understand the informed consent or the screening questions
because of language barriers, (6) inpatients treated in the ED, (7)
patients treated in the ED not for emergency reasons, as well as
(8) staff members of the hospital. Recruiting times were 8 am to
4 pm in week 1, 1 pm to 9 pm in week 2. Additionally, one
Saturday per month patients were recruited from 11 am to
9 pm.
Sample size
At the time of the study enrolment, limited evidence on ETC
efficacy (see above) did not allow a calculation of effect sizes.
Therefore, the sample size calculation was based on tobacco
control findings in hospitalised patients: tobacco control
showed superiority over usual care conditions only with a
combination of an initial intervention during hospital stay
followed by supportive contacts for at least 1 month after
discharge.
13 Assuming a rate of 20% abstinence in the control
group
13 and an effect size of the intervention of 1.8 (95% CI 1.5
to 2.2),
13 with an a error of 5% and a power of 80%, nQuery
Advisor, V. 3.0 (Statistical Solutions, Saugus, Massachusetts,
USA) calculated without continuity correction a study size of
n1 (intervention)=n2 (controls)=244 study participants. With
an expected loss to follow-up of 50% of smokers over
12 months,
14 the overall study size was established at 976. We
assumed additional losses of 5% (n=49) due to inappropriate
allocation or incomplete baseline screening and thus the target
size for study inclusion was n=1024 randomised participants.
Randomisation
After written informed consent, all consecutive patients were
administered a computerised screening tool. Study participants
were randomly assigned to either the ETC group or the control
group, stratified for age (three age groups: 18–25 years, 26–40
years and >41 years), gender and motivation to change smoking
behaviour (unmotivated, ambivalent and motivated smokers;
see below) based on the first three questions of the compu-
terised screening tool. Neither study participants nor staff
members on-site knew about the allocation, but the two senior
researchers responsible for the ETC (BN, EWG) were informed
via short message service (SMS) about a positive allocation.
Study participants received this information after they had
completed the questionnaire.
Baseline screening
The computerised screening tool at baseline, using a mouse-only
technique requiring no typing, consisted of a question on
motivation to change smoking behaviour according to the
transtheoretical model of behaviour change:
15 ‘‘When do you
wish to stop smoking?’’. Those answering ‘‘Not within the next
6 months’’ were considered unmotivated smokers (ie, smokers
in the precontemplation stage), those answering ‘‘Within the
next 6 months but not within the next 4 weeks’’ were
considered ambivalent smokers (ie, smokers in the contempla-
tion stage) and those answering ‘‘Within the next 4 weeks’’
were considered to be motivated smokers (ie, smokers in the
preparation stage).
16 Study participants were additionally
administered the validated German version
17 of the
Fagerstroem test for nicotine dependence (FTND),
18 a detailed
smoking history which includes questions on smoking history
(duration of smoking, age at onset, attempts to quit during the
last 12 months and partner’s smoking status).
19 Further ques-
tions focused on alcohol consumption (hazardous alcohol
consumption defined as >5 points on the Alcohol Use
Disorder Identification Test – Primary Care (AUDIT-PC)
20
scale), illicit drug consumption,
14 and socioeconomic parameters
according to the German Health Survey 1998.
21 Overall, a
maximum of 80 questions were asked, which took approxi-
mately 20 min. The questioning took place in the ED during
waiting times for treatment or diagnostic procedures. Routine
medical treatment was given priority over study assessment
procedures.
Intervention
Study participants in the intervention group received ETC in
the form of an on-site counselling session and telephone booster
follow-up sessions (TBSs). The ETC was conducted according
to recent guidelines on tobacco control from the Association of
the Scientific Medical Societies in Germany,
22 based on the
meta-analytical findings of Fiore,
23 Silagy
24 and West et al.
25 ETC
consisted of a smoking cessation intervention using motiva-
tional techniques and aimed at unmotivated or ambivalent
smokers who were willing to undergo on-site counselling of
more than 1–3 min. In motivated smokers, the focus of the
intervention was on behavioural support. Overall, the principle
of the five ‘‘A’’s was applied (‘‘ask’’, ‘‘advice’’, ‘‘assess’’, ‘‘assist’’
and ‘‘arrange’’)
23 as shown in fig 1. All patients were given
strong advice to quit. In study participants willing to continue
on-site counselling but unwilling to agree on a quitting day,
motivational interviewing according to the five ‘‘R’’s (‘‘rele-
vance’’, ‘‘risks’’, ‘‘rewards’’, ‘‘roadblocks’’ and ‘‘repetition’’) was
performed.
23 Study participants willing to stop smoking or to
reduce their smoking were offered behavioural support
25
including nicotine replacement therapy (gum, patch, sublingual
tablets) according to recent guidelines.
22 Nicotine replacement
therapy was provided free of charge on site. The primary goal of
ETC was to motivate participants to quit or to agree on a quit
date. The aim of the TBSs was to either further motivate the
study participant toward behavioural change (‘‘repeat’’/‘‘assist’’
components) and to ‘‘arrange’’ quit attempts or the main-
tenance of nicotine abstinence. The time frames and frequency
of the TBSs were arranged with the study participants. Times
for TBSs were Monday to Saturday from 9 am until 8 pm. If the
study participant was not reached at the agreed time, up to four
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unavailable following five attempts were considered to have
an incomplete ETC (meaning the on-site counselling alone or
on-site counselling in combination with one to three TBSs).
ETC was conducted by two senior researchers (BN, EWG) who
were not involved in the routine treatment of the ED patients.
Both researchers were trained in tobacco control interventions
by an independent research and teaching institute on the
therapy of addictive disorders. A fidelity check on the adherence
with recent guidelines was performed for each study participant
and the fidelity checks were analysed within a 90-min super-
vision session by a therapist every 4 weeks.
Follow-up
The primary study outcome was 7-day abstinence at the 12-
month follow-up. Additionally the 7-day abstinence at 1, 3 and
6 months was evaluated independently of the study arm by
staff members who were blinded to the group assignment.
Study participants were additionally asked for changes in
address, telephone number, and email address in order to
minimise attrition due to inappropriate reachability. Telephone
interviews were arranged at times that were convenient for
study participants. Telephone interviews took place Monday to
Friday from 10 am to 9 pm and on Saturdays from 10 am to
6 pm. At each time point, three attempts were made to reach
Figure 1 Stages of the on-site
counselling in the Emergency
Department.
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posted. Those unreachable after these four attempts were
categorised, at the specific time point, as ‘‘discontinued follow-
up’’, but were contacted at the next time point with the same
procedure. Follow-up telephone interviews were carried out
between November 2005 and January 2008. To validate the self-
reported smoking intensity at the 12-month follow-up, exhaled
carbon monoxide concentration (CO) was measured in a
subsample of 100 study participants living in the greater
Berlin area. Between March and November 2007 CO measures
took place in participants’ homes or in the ED if study
participants were willing to again visit the ED. One staff
member contacted 188 study participants before this number
could be reached (28 declined to participate, in 34 no
appointment for a CO measurement within 1 month was
possible and 26 could not be contacted or did not attend the
scheduled appointment). CO was measured using a NeoMed
EC50 CO analyser (Smokerlyser series no. 41693; NeoMed
Medical Technology, Korschenbroich, Germany). The cut-off of
was chosen as 6.5 parts per million (ppm) CO in the exhaled air
as previous reported.
26
Statistical analysis
All binary and categorical variables are shown as frequencies.
Metric variables are shown as medians (ranges). In study
participants with complete baseline screening, smoking-related
variables and socioeconomic parameters were compared across
the ETC and control groups using the Mann–Whitney U test for
metric variables and the x
2 test for nominal respectively ordinal
variables. The Jonckheere–Terpstra test was used to compare
metric variables and the Mantel–Haenszel test for trend was
used to compare nominal respectively ordinal variables across
the three stages of motivation to change behaviour. Intention-
to-treat analysis of the primary study outcome was by binary
Figure 2 Flowchart of all patients,
baseline enrolment and follow-up.
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control (ETC) group and control group in patients with complete baseline screening, n=1012
Parameter
All patients ETC group Control group
p Value n=1012 (100%) n=505 (49.9%) n=507 (50.1%)
Age in years, median (range) 30 (18–78) 29 (18–78) 30 (18–72) 0.35
Gender, n (%):
Male 614 (60.7) 308 (61.0) 306 (60.4) 0.84
Female 398 (39.3) 197 (39.0) 201 (39.6)
Motivation to change smoking behaviour,
n (%)*:
Unmotivated smokers 557 (55.0) 280 (55.4) 277 (54.6)
Ambivalent smokers 327 (32.3) 163 (32.3) 164 (32.3) 0.73{
Motivated smokers 128 (12.6){ 62 (12.3) 66 (13.0){
No. of cigarettes smoked per day during
the last 7 days, median (range)
15 (1–60) 15 (1–60) 16 (1–50) 0.04
Nicotine dependency, n (%)1:
Low 424 (41.9) 222 (44.0) 202 (39.8)
Medium 241 (23.8) 112 (22.2) 129 (25.4) 0.36{
High 347 (34.3) 171 (33.9){ 176 (34.7){
Smoking duration, n (%):
,1 year 25 (2.5) 16 (3.2) 9 (1.8)
1–3 years 81 (8.0) 41 (8.1) 40 (7.9) 0.39{
4–10 years 386 (38.1) 191 (37.8) 195 (38.5)
.10 years 520 (51.4) 257 (50.9) 263 (51.9){
Age of smoking onset, n (%):
,14 years 151 (14.9) 80 (15.8) 71 (14.0)
14–16 years 375 (37.1) 192 (38.0) 183 (36.1)
17–18 years 227 (22.4) 105 (20.8) 122 (24.1) 0.36{
19–30 years 245 (24.2) 121 (24.0) 124 (24.5)
.30 years 14 (1.4) 7 (1.4) 7 (1.4){
Attempts to quit smoking during the
last 12 months, n (%):
None 584 (57.7) 275 (54.5) 309 (60.9)
1 232 (22.9) 126 (25.0) 106 (20.9) 0.08{
2–5 159 (15.7) 84 (16.6) 75 (14.8)
.5 37 (3.7) 20 (4.0)1 17 (3.4)
Partner smoking, n (%):
No 280 (27.7) 134 (26.5) 146 (28.8)
Yes 434 (42.9) 217 (43.0) 217 (42.8) 0.66
No partnership 298 (29.4) 154 (30.5) 144 (28.4)
Hazardous alcohol consumption, n (%)":
Yes 349 (34.5) 177 (35.0) 172 (33.9) 0.71
No 663 (65.5) 328 (65.0) 335 (66.1)
Illicit drug use (last 12 months), n (%):
None 614 (60.7) 299 (59.2) 315 (62.1)
1–3 times 158 (15.6) 83 (16.4) 75 (14.8) 0.58{
4 times up to weekly 131 (12.9) 70 (13.9) 61 (12.0)
Several times per week to daily 109 (10.8) 53 (10.5) 56 (11.0){
Types of drugs in illicit drug users
(n=398), n (%):
Cannabis only 201 (50.5) 104 (50.5) 97 (50.5)
Ecstasy/designer drugs only 15 (3.8) 4 (1.9) 11 (5.7) 0.18
Cocaine only 1 (0.3) 1 (0.5) 0 (0.0)
All other combinations 181 (45.5){ 97 (47.1) 84 (43.8)
School education, n (%):
Discontinued 13 (1.3) 10 (2.0) 3 (0.6)
10 years 484 (47.8) 232 (45.9) 252 (49.7) 0.18
11–13 years 501 (49.5) 256 (50.7) 245 (48.3)
In school education 14 (1.4) 7 (1.4) 7 (1.4)
Current occupation, n (%):
Full time working 495 (48.9) 252 (49.9) 243 (47.9)
Unemployed 96 (9.5) 47 (9.3) 49 (9.7) 0.82
All other 421 (41.6) 206 (40.8) 215 (42.4)
Marital status, n (%):
Married, living with the partner 153 (15.1) 68 (13.5) 85 (16.8)
Continued
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logistic in SAS V. 9.1 (SAS Institute, Cary, North Carolina,
USA) with the contrast-statement to evaluate the effect of ETC
stratified for motivation). Study participants not reached at
follow-up were assumed to be continuous smokers. Subgroup
analysis in the 1012 study participants with complete baseline
screening regarding 7-day abstinence at 12 months additionally
included the degree of nicotine dependency, the latter men-
tioned as independent predictor of smoking cessation.
27 28 A
p(0.05 (two-sided) was determined as being significant. All
statistical analysis was performed using SAS software.
RESULTS
In total, 11 218 consecutive patients were assessed for eligibility
(fig 2). Overall, 4992 (44.5%) did not meet the inclusion criteria.
Of 6226 patients questioned about their smoking status, 4498
(72.2%) were non-smokers. This left 1728 potential study
participants. Of these, 684 (39.6% of 1728) refused study
participation. Reasons for non-participation are given in fig 2.
Overall, 1044 patients were randomised (515 in the ETC and
529 in the control group). There was no difference between the
ETC group and the control group with regard to the proportion
of male study participants (311/515, 60.4% vs 319/529, 60.3%,
p=0.98), motivation to change smoking behaviour (286/515,
55.5% unmotivated, 165/515, 32.0% ambivalent and 64/515,
12.4% (percentage does not sum up to 100% because of
rounding error) motivated smokers vs 294/529, 55.6% unmoti-
vated, 166/529, 31.4% ambivalent and 69/529, 13.0% motivated
smokers, Mantel–Haenszel test for trend: p=0.90) and the
median age at baseline (29 (range 18–78) years vs 30 (range 18–
72) years, p=0.35).
In the ETC group 10 study participants, and in the control
group 22 study participants, discontinued baseline screening
after the randomisation, leaving 1012 study participants with
complete baseline screening. Another 33 patients in the ETC
group (6.4% of 515) refused on-site counselling or immediately
left the study site. Table 1 shows baseline patient characteristics
in the ETC group compared to the control group in those 1012
study participants with complete baseline screening. Significant
differences were found in the median number of cigarettes
smoked per day (ETC group 15 (range 1–60) compared to 16
(range 1–50) in the control group, p=0.04) and regarding size of
household (p=0.03). The majority of study participants
(51.4%) had smoked for more than 10 years, and more than
half had started smoking before age 17.
Differences between motivation to change smoking groups
(see table 2) in those 1012 study participants with complete
baseline screenings were found regarding time variables (longer
smoking duration and earlier onset of smoking in less motivated
smokers) and attempts to quit smoking (more attempts in
higher motivated smokers).
For study participants in the ETC group, table 3 shows the
characteristics of the ETC as well as differences in subgroups
stratified for motivation to change smoking behaviour. The
overall median time of ETC for the 472 study participants
who received at least the on-site counselling was 30 (range
1–99) min, with the on-site counselling taking a median
duration of 13 (range 1–45) min. Less than half (230 out of
515, 44.7%) of the ETC group completed the ETC.
Approximately 15% of the 472 ETC participants who received
at least the on-site counselling chose nicotine replacement
therapy. Significant differences in different subgroups of
motivation to change smoking behaviour were found regarding
the time of the on-site counselling and the overall duration of
ETC, the proportion of study participants who received nicotine
replacement therapy (NRT) or agreed on a quitting day.
Table 1 Continued
Parameter
All patients ETC group Control group
p Value n=1012 (100%) n=505 (49.9%) n=507 (50.1%)
Married, living separate 34 (3.4) 19 (3.8) 15 (3.0) 0.42
Widowed/divorced 82 (8.1) 39 (7.7) 43 (8.5)
Single 743 (73.4) 379 (75.0) 364 (71.8){
Size of household, n (%):
1 person 388 (38.3) 210 (41.6) 178 (35.1) 0.03
.1 person 624 (61.7) 295 (58.4) 329 (64.9)
Net family income/month, n (%):
Below average** 473 (46.7) 239 (47.3) 234 (46.2) 0.54
Above average** 298 (29.4) 141 (27.9 157 (31.0)
No data 241 (23.8){ 125 (24.8) 116 (22.9){
Family doctor, n (%):
Yes 724 (71.5) 359 (71.1) 365 (72.0) 0.75
No 288 (28.5) 146 (28.9) 142 (28.0)
Visits to the family doctor (last 12 months) in
patients with a family doctor (n=724), n (%):
None 63 (8.7) 28 (7.8) 35 (9.6)
1 or 2 353 (48.8) 173 (48.2) 180 (49.3) 0.32{
3 or more 308 (42.5) 158 (44.0) 150 (41.1)
Medical status, n (%):
Surgical 485 (47.9) 238 (47.1) 247 (48.7) 0.61
Internal 527 (52.1) 267 (52.9) 260 (51.3)
Significant values are in bold.
*‘‘When do you wish to stop smoking?’’ (‘‘not within the next 6 months’’=unmotivated smokers, ‘‘within the next 6 months but
not within the next 4 weeks’’=ambivalent smokers and ‘‘within the next 4 weeks’’=motivated smokers); {Mantel–Haenszel test
for trend; {does not sum up to 100% because of rounding error; 1measured with the Fagerstroem test for nicotine dependency;
‘‘low’’=0–2 points, ‘‘medium’’=3–4 points, ‘‘high’’=5–10 points; "measured with the AUDIT-PC questionnaire; ‘‘no’’=0 to 4
points, ‘‘yes’’=5 to 20 points; **average=mean net household income per month in Berlin in 2004 (ie, J1725).
29
AUDIT-PC, Alcohol Use Disorder Identification Test – Primary Care.
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motivated smokers, compared to ambivalent or unmotivated
smokers, agreed on a quitting day and/or received NRT.
At the 12-month follow-up 685 participants (65.6% of 1044)
could be reached. As shown in fig 2, 177 out of 515 (34.4%)
study participants in the ETC group were lost to follow-up
(therein 10 study participants who discontinued the baseline
questionnaire) and 182 out of 529 study participants (34.4%) in
the control group were lost to follow-up (therein 22 study
participants who discontinued the baseline questionnaire).
Table 4 shows the results of the non-responder analysis.
Responders were a median age of 1 year older, more often
women, less nicotine dependent, less often characterised by
additional substance use, more highly educated and were more
likely to have a family doctor.
The results on 7-day abstinence in the ETC group versus the
control group based on intention-to-treat were overall 73/515
(14.2%) vs 60/529 (11.3%). In unmotivated smokers 26/286
(9.1%) in the ETC group and 27/294 (9.2%) in the control group
were abstinent, whereas in ambivalent smokers 26/165 (15.8%)
in the ETC group and 20/166 (12.0%) in the control were
abstinent. In motivated smokers 21/64 (32.8%) in the ETC
group and 13/69 (18.8%) in the control group were abstinent,
respectively. This translates, after adjustment for age and
gender, to an overall odds ratio of 1.31 (95% CI 0.91 to 1.89),
p=0.15 for the ETC group vs the control group (model 1 in
fig 3). Additional adjustment for motivation to change smoking
behaviour did not change the estimate of ETC vs the control
group. The estimate for motivation to change smoking
behaviour was highly significant (p for trend ,0.001, model
2a in fig 3). The interaction between ETC and motivation
(model 2b in fig 3) revealed no effect of ETC vs the control
group in unmotivated smokers, a non-significant positive effect
of ETC vs the control group in ambivalent smokers and a more
than twofold non-significant effect of ETC vs the control group
in motivated smokers. The test for trend for the interaction of
ETC and motivation was not significant, p=0.29.
A subgroup analysis in 1012 study participants with complete
baseline screening (model 3 in fig 3) revealed an independent
negative effect of nicotine dependence on 7-day abstinence at
12 months while the effect of ETC vs the control group in
motivated smokers became significant. The interaction of ETC
Table 2 Age, gender and smoking related variables stratified according to the motivation to change
behaviour in patients with complete baseline screening, n=1012
Parameter
Stratified according to the motivation to change smoking
behaviour at baseline*
p Value
Unmotivated
smokers
Ambivalent
smokers Motivated smokers
n=557 (55.0%) n=327 (32.3%) n=128 (12.6%){
Age in years, median (range) 29 (18–72) 30 (18–73) 30.5 (19–78) 0.48{
Gender, n (%):
Male 339 (60.9) 192 (58.7) 83 (64.8) 0.701
Female 218 (39.1) 135 (41.3) 45 (35.2)
No. of cigarettes smoked per day during the
last 7 days, median (range)
15 (1–60) 16 (1–50) 10 (1–60) 0.12{
Nicotine dependency, n (%)":
Low 229 (41.1) 138 (42.2) 57 (44.5) 0.491
Medium 133 (23.9) 79 (24.2) 29 (22.7)
High 195 (35.0) 110 (33.6) 42 (32.8)
Smoking duration, n (%):
,1 year 6 (1.1) 8 (2.4) 11 (8.6) 0.0031
1–3 years 45 (8.1) 23 (7.0) 13 (10.2)
4–10 years 212 (38.1) 128 (39.1) 46 (35.9)
.10 years 294 (52.8){ 168 (51.4){ 58 (45.3)
Age of smoking onset, n (%):
,14 years 83 (14.9) 46 (14.1) 22 (17.2) 0.0431
14–16 years 224 (40.2) 112 (34.3) 39 (30.5)
17–18 years 122 (21.9) 78 (23.9) 27 (21.1)
19–30 years 123 (22.1) 87 (26.6) 35 (27.3)
.30 years 5 (0.9) 4 (1.2){ 5 (3.9)
Attempts to quit smoking during the last 12
months, n (%):
None 411 (73.8) 143 (43.7) 30 (23.4) ,0.0011
1 89 (16.0) 97 (29.7) 46 (35.9)
2–5 44 (7.9) 80 (24.5) 35 (27.3)
.5 13 (2.3) 7 (2.1) 17 (13.3){
Partner smoking, n (%):
No 134 (24.1) 99 (30.3) 47 (36.7) 0.083
Yes 261 (46.9) 130 (39.8) 43 (33.6)
No partnership 162 (29.1){ 98 (30.0){ 38 (29.7)
Significant values are in bold.
*‘‘When do you wish to stop smoking?’’ (‘‘not within the next 6 months’’=unmotivated smokers, ‘‘within the next 6 months but
not within the next 4 weeks’’=ambivalent smokers and ‘‘within the next 4 weeks’’=motivated smokers); {does not sum up to
100% because of rounding error; {Jonckheere–Terpstra test; 1Mantel–Haenszel test for trend; "measured with the Fagerstroem
test for nicotine dependency; ‘‘low’’=0–2 points, ‘‘medium’’=3–4 points, ‘‘high’’=5–10 points.
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respectively.
Of the 100 study participants with CO measured in the
exhaled air at 12-month follow-up, 1 dataset could not be used
because of technical failure of the CO measurement. Of the
remaining 99 study participants 18 reported 7-day abstinence
(see table 5). Sensitivity was 80.2% and specificity was 88.9%.
The area under the receiver-operated curve (ROC) equalled
0.880 (95% CI 0.776 to 0.984).
DISCUSSION
These results confirm previous findings of no overall effect of
ETC.
568 – 1 0Patients’ motivation to quit was a strong predictor of
smoking cessation at follow-up as previously reported.
11
Concerning unmotivated smokers, our approach does not seem
to have any advantages over usual care. Thus, one consequence
of our findings might be to limit ETC in unmotivated smokers
to brief advice. Law and Tang
30 in their analysis of 188 trials
found a smoking cessation rate of 2% (95% CI 1% to 3%)
following personal advice and encouragement to stop smoking
given by doctors during a single routine consultation. Silagy,
24 in
a meta-analysis of 16 trials of brief advice versus no advice (or
usual care), revealed a small but significant increase in the
cessation rate of about 2.5%. Taking the lower limit of the 95%
CI of a single routine consultation,
30 these findings would
translate into a number needed to treat (NNT) of 100, or an
overall consultation time of 100–300 min for 1 additional
smoking cessation.
2 During on-site counselling in this investiga-
tion, several unmotivated smokers suggested intervals for the
telephone booster follow-up sessions of 6 to 12 months (which
could not be scheduled because of the study protocol). We
interpreted this suggestion as a request for a long-term, low
threshold tobacco control program. Therefore, another option
might be to evaluate, in future studies, whether unmotivated
smokers treated in EDs profit from a longer-term supportive
therapeutic regimen, initiated on-site and maintained thereafter
(eg, by a general practitioner; around 72% of unmotivated
smokers had a family doctor, of these 90% with a minimum one
visit during the last 12 months; data not shown).
In ambivalent smokers, our results showed a non-significant
benefit of tobacco control over standard care with a 3.8%
difference in 7-day abstinence rates at 12 months in an
intention-to-treat analysis. The overall study was not designed
to demonstrate differences in subgroups. Assuming clinical but
not statistical significance due to an inappropriate number of
study participants in this subgroup, the results would
translate into a NNT of around 26 and a median treatment
time of 884 min (the median time for 1 ETC in ambivalent
s m o k e r si nt h i si n v e s t i g a t i o nw a s3 4m i n )f o r1a d d i t i o n a l
smoking cessation. Thus, for ambivalent smokers who account
for one third of the ED patients, alternative treatment regimes
must be developed.
In motivated smokers we observed a 14.0% difference in 7-
day abstinence rates at 12 months, with a NNT of around 7.
This difference is based on a relatively small number of
observations and should be interpreted cautiously. However, it
would translate into an overall median treatment time of
245 min (the median time for one ETC in motivated smokers
in this investigation was 35 min) to achieve one additional
smoking cessation at 12 months. This finding would be
consistent with the overall time for one additional smoking
cessation after brief advice in unmotivated smokers (see
above). In this investigation, being more highly motivated
was associated with a shorter smoking duration and a higher
age of smoking onset. Higher motivated smokers already had
the most experience with quitting attempts within the last 12
months. When offered ETC, motivated smokers more inten-
sively used the proposed consulting and were more often than
unmotivated or ambivalent smokers willing to agree on a
quitting day or to use NRT.
Table 3 Emergency Department-initiated tobacco control (ETC) in study participants with complete baseline screening, allocated to intervention and
stratified for the motivation to change smoking behaviour, n=515
All patients in the
ETC group
Patients in the ETC group stratified according to the motivation to
change smoking behaviour at baseline*
p Value
Unmotivated
smokers Ambivalent smokers Motivated smokers
n=515 (100%) n=286 (55.5%) n=165 (32.0%) n=64 (12.4%){
No. of contacts during ETC, n (%):
0 (no ETC) 43 (8.3) 24 (8.4) 16 (9.7) 3 (4.7)
1 (‘‘only’’ on-site counseling) 64 (12.4) 36 (12.6) 19 (11.5) 9 (14.1)
2 48 (9.3) 30 (10.5) 11 (6.7) 7 (10.9) 0.31{
3 61 (11.8) 41 (14.3) 15 (9.1) 5 (7.8)
4 69 (13.4) 32 (11.2) 27 (16.4) 10 (15.6)
5 (complete ETC) 230 (44.7){ 123 (43.0) 77 (46.7){ 30 (46.9)
Time of the on-site counselling in min (n=472)1,
median (range)
13 (1–45) 12 (1–45) 15 (1–35) 17 (1–35) 0.002"
Only on-site counselling of 1–3 min (n=472), n (%):1
Yes 20 (4.2) 11 (4.2) 6 (4.0) 3 (4.9) 0.87{
Overall time of ETC in min (n=472), median (range)1 30 (1–99) 27 (1–75) 34 (2–99) 35 (1–77) ,0.001"
Received nicotine replacement therapy (n=472), n (%):1
Yes 70 (14.8) 28 (10.7) 28 (18.8) 14 (23.0) 0.004{
Agreed on a quitting day during the on-site counselling
(n=472), n (%):1
Yes 83 (17.6) 39 (14.9) 28 (18.8) 16 (26.2) 0.036{
Significant values are in bold.
*‘‘When do you wish to stop smoking?’’ (‘‘not within the next 6 months’’=unmotivated smokers, ‘‘within the next 6 months but not within the next 4 weeks’’=ambivalent
smokers and ‘‘within the next 4 weeks’’=motivated smokers); {does not sum up to 100% because of rounding error; {Mantel–Haenszel test for trend; 1only those study
participants who were allocated to intervention and received at least the on-site counselling; "Jonckheere–Terpstra test.
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Although study participants were randomised, stratified for age,
gender and motivation to change behaviour, a statistical
significant difference in the number of cigarettes per day
between both study arms was observed. The median difference
of one cigarette per day between groups, however, is probably of
little clinical significance.
Because of the limited evidence on ETC at the time of study
enrolment the sample size calculation was based on findings of
inpatients showing an overall Peto odds ratio (OR) of 1.82 (95%
CI 1.49 to 2.22) in tobacco control interventions with
supportive contacts for at least 1 month compared with control
condition.
13 An update of this meta-analysis in 2007 based on 17
trials found a weaker overall effect of tobacco control (Peto
OR=1.65 (95% CI 1.4 to 1.9)).
31 Thus, the study size
calculation for this investigation was probably based on
overestimated findings and led to incorrect sample sizes. ETC
may be less effective than tobacco control in non-ED patients,
due to a high prevalence of conjoint substance use and a cluster
of further medical and social risks in ED patients. Another
reason for the overall failure of ETC may be its initial
application in an often hectic setting, one that hinders the
establishment of a therapeutic relationship that is significant
enough to assist the patient through the tobacco quitting
process.
Findings from this study regarding baseline as well as follow-
up enrolment must be seen as being impacted by potential
selection bias during study participation assessment, incomplete
allocation and incomplete ETC interventions. Richman et al
reported complete allocation to intervention in their ED-based
RCT in 152 out of 216 eligible patients (70.4%) and a 3-month
follow-up of 103 (67.8%) study participants.
5 Referral to a
smoking cessation programme was accepted by less than half of
1095 smokers in the ED-based feasibility study by Cummings
Table 4 Comparison between responder and non-responder groups at 12 months, n=1044
Parameter
Responders Non-responders
p Value n=685 (65.6%) n=359 (34.4%)
Randomisation, n (%):
ETC group 338 (49.3) 177 (49.3) 0.990
Control group 347 (50.7) 182 (50.7)
Age in years, median (range) 30 (18–81) 29 (18–78) ,0.001
Gender, n (%):
Male 396 (57.8) 234 (65.2) 0.021
Female 289 (42.2) 125 (34.8)
No. of cigarettes smoked per day during the last 7 days
(n=1012), median (range)
15 (1–60) 15 (1–60) 0.124
Nicotine dependency (n=1012), n (%):*
Low 310 (45.3) 114 (34.9)
Medium 158 (23.1) 83 (25.4) 0.002{
High 217 (31.7){ 130 (39.8){
Motivation to change smoking behaviour, n (%)1:
Unmotivated smokers 375 (54.7) 205 (57.1)
Ambivalent smokers 227 (33.1) 104 (29.0) 0.905{
Motivated smokers 83 (12.1){ 50 (13.9)
Attempts to quit smoking during the last 12 months (n=1012),
n (%):
None 395 (57.7) 189 (57.8)
1 153 (22.3) 79 (24.2) 0.667{
2–5 111 (16.2) 48 (14.7)
.5 26 (3.8) 11 (3.4){
Hazardous alcohol consumption (n=1012), n (%):"
Yes 221 (32.3) 128 (39.1) 0.031
No 464 (67.7) 199 (60.9)
Illicit drug use (last 12 months) (n=1012), n (%):
None 430 (62.8) 184 (56.3)
1–3 times 109 (15.9) 49 (15.0) 0.006{
4 times up to weekly 84 (12.3) 47 (14.4)
Several times per week to daily 62 (9.1){ 47 (14.4){
School education (n=1012), n (%):
Discontinued 5 (0.7) 8 (2.4)
10 years 311 (45.4) 173 (52.9) ,0.001
11–13 years 364 (53.1) 137 (41.9)
In school education 5 (0.7){ 9 (2.8)
Family doctor (n=1012), n (%):
Yes 507 (74.0) 217 (66.4) 0.012
No 178 (26.0) 110 (33.6)
*Measured with the Fagerstroem test for nicotine dependency, ‘‘low’’=0–2 points, ‘‘medium’’=3–4 points, ‘‘high’’=5–10
points; {Mantel–Haenszel test for trend; {does not sum up to 100% because of rounding error; 1‘‘When do you wish to stop
smoking?’’ (‘‘not within the next 6 months’’=unmotivated smokers, ‘‘within the next 6 months but not within the next
4 weeks’’=ambivalent smokers and ‘‘within the next 4 weeks’’=motivated smokers); "measured with the AUDIT-PC
questionnaire: ‘‘no’’=0 to 4 points, ‘‘yes’’=5 to 20 points.
AUDIT-PC, Alcohol Use Disorder Identification Test – Primary Care; ETC, Emergency Department-initiated tobacco control.
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7 Schiebel and Ebbert found in their feasibility study that
152 out of 212 smokers who initially indicated interest in
quitting decided not to participate in their study and of those 39
finally randomised, 19 (48.7%) could not be reached or refused
the 6-month follow-up.
8 In our investigation, selection bias of
those finally agreeing to study participation (1044 out of 1728)
may have led to a positive sampling of those being more
susceptible to health promotion since more than half of those
smokers who refused participation were not interested in a
study on tobacco control. Recall biases during follow-up may
have further impacted on the validity of the results. But we
assume that selection biases through discontinuation of the
follow-up—in this study strongly associated with the degree of
nicotine dependency as well as additional substance use
parameters but independent of the motivation for behavioural
change—was adequately controlled through our statistical
approach.
The validation of self-reported smoking intensity through CO
measurement in the exhaled air was conducted in a subsample
of 100 out of 188 study participants leaving 99 datasets for
analysis. Although validity in the subsample was satisfactory,
the overall validity of the self-reported results on smoking
cessation still remains questionable. But, our finding on the
proportion of smoking deceivers (self-reported non-smokers
chemically classified as smokers) was in the range of 4.0% and
13.0% smoking deceivers evaluated in previous studies on the
validation of self-reported smoking.
30 32 33
Figure 3 ORs and their corresponding 95% CIs of the effect of Emergency Department-initiated tobacco control vs the control group on 7-day
abstinence at 12-month follow-up adjusted for age and gender, n=1044 (models 1 and 2) and subgroup analysis in patients with complete baseline
screening, n=1012 (model 3).
Table 5 Carbon monoxide in parts per million (ppm) in the exhaled air
at 12-month follow-up, n=99
CO concentration*
Self-reported
smokers
Self-reported non-
smokers{ n (%)
>7 ppm 65 (80.2%) 2 (11.1%) 67 (67.7%)
0–6.5 ppm 16 (19.8%) 16 (88.9%) 32 (32.3%)
n (%) 81 (100%) 18 (100%) 99 (100%)
*Measured with a NeoMed EC50 CO analyser (see Methods); {7-day abstinence.
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future implementation into clinical routine, our study clearly
showed the feasibility of ETC during routine activity in an
urban ED. ETC, in the form tested in this investigation, appears
to enhance the patient’s self-motivation in ambivalent and
motivated smokers. The negative impact of nicotine dependence
probably reflects the limiting (physical) factors in patient
baseline characteristics. Systematically evaluating the benefit
of nicotine replacement therapy in ETC services might
adequately address these limiting factors in the future.
Nicotine replacement therapy may further reduce attrition
rates with ETC services since in this investigation higher
nicotine dependency, but not lower motivation to change
smoking behaviour, was associated with loss to follow-up.
Acknowledgements: The authors thank Sven Andre ´asson, Stockholm, Sweden; Anil
Batra, Tuebingen Germany; Andreas Heinz, Berlin, Germany, Karl Mann, Mannheim,
Germany and Hanne Tønnesen, Copenhagen, Denmark, for their scientific support. The
authors thank Su ¨kran Cosgun, Juliane Freudenberger, Alexandra Gildemeister, Rebekka
Kebesch, Vanessa Maerz, Phillip Petri, Katja Reuthner, Hannah Trenkner, Julia Weber,
Larissa Weber and Martin Winter for their work during the study enrolment. The
authors further thank the staff members of the Emergency Department at Charite ´–
Universitaetsmedizin Berlin, Campus Charite ´ Mitte for their continuous support.
Funding: This study was funded by the German Cancer Foundation (Deutsche
Krebshilfe), Bonn, Germany (Grant DKH-106730).
Competing interests: None.
Ethics approval: This study was approved by the Ethical Committee Board of Charite ´–
Universitaetsmedizin Berlin, Berlin, Germany.
REFERENCES
1. Bernstein SL, Cannata M. Nicotine dependence, motivation to quit, and diagnosis in
emergency department patients who smoke. Addict Behav 2006;31:288–97.
2. Bernstein SL, Boudreaux ED, Cydulka RK, et al. Tobacco control interventions in the
emergency department: a joint statement of emergency medicine organizations. Ann
Emerg Med 2006;48:e417–26.
3. Pollock DA, Lowery DW, O’Brien PM. Emergency medicine and public health: new
steps in old directions. Ann Emerg Med 2001;38:675–83.
4. Bernstein SL, Becker BM. Preventive care in the emergency department: diagnosis
and management of smoking and smoking-related illness in the emergency
department: a systematic review. Acad Emerg Med 2002;9:720–9.
5. Richman PB, Dinowitz S, Nashed AH, et al. The emergency department as a
potential site for smoking cessation intervention: a randomized, controlled trial. Acad
Emerg Med 2000;7:348–53.
6. Antonacci MA, Eyck RT. Utilization and effectiveness of an emergency department
initiated smoking cessation program. Acad Emerg Med 2000;7:1166.
7. Cummings GE, Francescutti LH, Predy G, et al. Health promotion and disease
prevention in the emergency department: a feasibility study. Can J Emerg Med
2006;8:100–5.
8. Schiebel NE, Ebbert JO. Quitline referral vs. self-help manual for tobacco use
cessation in the emergency department: a feasibility study. BMC Emerg Med
2007;7:15.
9. Horn K, Dino G, Hamilton C, et al. Efficacy of an emergency department-based
motivational teenage smoking intervention. Prev Chronic Dis 2007;4:A08.
10. Horn K, Dino G, Hamilton C, et al. Feasibility of a smoking cessation intervention for
teens in the emergency department: reach, implementation fidelity, and acceptability.
Am J Crit Care 2008;17:205–16.
11. Bock BC, Becker BM, Niaura RS, et al. Smoking cessation among patients in an
emergency chest pain observation unit: outcomes of the Chest Pain Smoking Study
(CPSS). Nicotine Tob Res 2008;10:1523–31.
12. Boudreaux ED, Baumann BM, Perry J, et al. Emergency department initiated
treatments for tobacco (EDITT): a pilot study. Ann Behav Med 2008;36:314–25.
13. Rigotti NA, Munafo MR, Murphy MF, et al. Interventions for smoking cessation in
hospitalised patients. Cochrane Database Syst Rev 2003;1:CD001837.
14. Neuner B, Fleming M, Born R, et al. Predictors of loss to follow-up in young patients
with minor trauma after screening and written intervention for alcohol in an urban
emergency department. J Stud Alcohol Drugs 2007;68:133–40.
15. Prochaska JO, Diclemente CC. The transtheoretical approach: crossing traditional
boundaries of therapy. Florence, Kentucky, USA: Brooks Cole, 1984.
16. Keller S, Velicer WF, Prochaska JO. Das transtheoretische Modell - eine U ¨bersicht
[in German]. In: Keller S, ed. Das transtheoretische Modell in Forschung und Praxis.
Freiburg, Germany: Lambertus, 1999: 17–44.
17. Schumann A, Rumpf HJ, Meyer C, et al. Deutsche Version des Fagerstroem test for
nicotine dependence (FTND-G) [in German]. In Elektronisches Handbuch zu
Erhebungsinstrumenten im Suchtbereich (EHES) version 3.0. Mannheim, Germany:
Zentrum fu ¨r Umfragen, Methoden und Analysen, 2003.
18. Heatherton TF, Kozlowski LT, Frecker RC, et al. The Fagerstrom test for nicotine
dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict
1991;86:1119–27.
19. Lindinger P. Die Rauchersprechstunde - Beratungskonzept fu ¨r Gesundheitsberufe [in
German]. Heidelberg, Germany: Deutsches Krebsforschungszentrum Rote Reihe
Tabakpra ¨vention und Tabakkontrolle, 2000.
20. Piccinelli M, Tessari E, Bortolomasi M, et al. Efficacy of the alcohol use disorders
identification test as a screening tool for hazardous alcohol intake and related
disorders in primary care: a validity study. BMJ 1997;314:420–4.
21. Bellach BM, Knopf H, Thefeld W. The German health survey 1997/98 [in German].
Gesundheitswesen 1998;60(Suppl 2):S59–68.
22. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen
Fachgesellschaften (AWMF). Tabakbedingte Sto ¨rungen ‘‘Leitlinie
Tabakentwo ¨hnung’’ [in German]. http://leitlinien.net (accessed 15 October 2008).
23. Fiore MC. US public health service clinical practice guideline: treating tobacco use
and dependence. Respir Care 2000;45:1200–62.
24. Silagy C. Physician advice for smoking cessation. Cochrane Database Syst Rev
2000;2:CD000165.
25. West R, McNeill A, Raw M. Smoking cessation guidelines for health professionals:
an update. Health Education Authority. Thorax 2000;55:987–99.
26. Deveci SE, Deveci F, Acik Y, et al. The measurement of exhaled carbon monoxide in
healthy smokers and non-smokers. Respir Med 2004;98:551–6.
27. Chaiton MO, Cohen JE, McDonald PW, et al. The Heaviness of Smoking Index as a
predictor of smoking cessation in Canada. Addict Behav 2007;32:1031–42.
28. Hyland A, Borland R, Li Q, et al. Individual-level predictors of cessation behaviours
among participants in the International Tobacco Control (ITC) Four Country Survey.
Tob Control 2006;15(Suppl 3):iii83–94.
29. Council of the Berlin Borough of Mitte. http://www berlin de/ba-mitte/bezirk/
daten/bevoelkerung.html (accessed 15 October 2008).
30. Law M, Tang JL. An analysis of the effectiveness of interventions intended to help
people stop smoking. Arch Intern Med 1995;155:1933–41.
31. Rigotti NA, Munafo MR, Stead LF. Interventions for smoking cessation in
hospitalised patients. Cochrane Database Syst Rev 2007;3:CD001837.
32. From AM, Herlitz J, Berndt AK, et al. Are patients truthful about their smoking
habits? A validation of self-report about smoking cessation with biochemical markers
of smoking activity amongst patients with ischaemic heart disease. J Intern Med
2001;249:145–51.
33. Murray RP, Connett JE, Lauger GG, et al. Error in smoking measures: effects of
intervention on relations of cotinine and carbon monoxide to self-reported smoking.
The Lung Health Study Research Group. Am J Public Health 1993;83:1251–7.
What this paper adds
c Although there is evidence that the smoking prevalence of
emergency department (ED) patients exceeds the smoking
prevalence in the population and a joint statement of US
Emergency Medicine Organizations encourages administrators
to implement tobacco control services, the effectiveness of
such services is still unclear.
c In a randomised controlled trial in more than 1000 ED patients
with a median smoking intensity of 15 cigarettes per day, ED-
initiated tobacco control (ETC) showed a non-significant
overall effect on 7-day abstinence at 12 months.
c Unmotivated smokers do not seem to profit from ETC while, in
ambivalent and motivated smokers, a non-significant clinical
effect of ETC was observed.
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